In the landscape of modern oncology, the clinical battle against breast cancer is increasingly supplemented by a powerful, often overlooked secondary treatment: community. For Tori Ashman, a mother and athlete, the journey from a routine health screening to a Stage 1B invasive ductal carcinoma diagnosis was not a solitary trek through medical corridors. Instead, it became a testament to the efficacy of specialized support systems. By leveraging the camaraderie of Mamanet, a recreational sports league, and the professional resources of Sharsheret, a leading cancer support organization, Ashman’s story offers a blueprint for how "sisterhood in motion" can fundamentally alter the trajectory of recovery and survival.
Main Facts: A Dual-Front Support System
Tori Ashman’s experience underscores two critical pillars of contemporary women’s health: the clinical necessity of early detection and the psychological necessity of community-based care. Ashman, who was diagnosed in early 2023, found herself at the center of a unique support structure.
Mamanet, an international mothers’ catchball league, provided the physical and emotional "team" atmosphere that allowed her to maintain a sense of identity beyond her diagnosis. Simultaneously, Sharsheret—a national non-profit organization dedicated to supporting Jewish women and families facing breast and ovarian cancer—provided the technical, financial, and peer-to-peer resources required to navigate a complex medical system.
The synergy between these two groups, combined with Ashman’s advocacy for early mammography, highlights a vital statistic: breast cancer caught in its earliest stages, before it has spread to distant organs, has a five-year relative survival rate of approximately 99%.
Chronology: The "Subscription Box" of Diagnosis
The timeline of Ashman’s journey began with a proactive step common to many women reaching a milestone age. At 40, she scheduled her baseline mammogram, a routine procedure that quickly spiraled into a multi-year cycle of medical scrutiny.
"When the technician said, ‘We just need a few more images,’ I thought, ‘Wow, my boobs are really photogenic,’" Ashman recalled. However, the levity was short-lived. A call from her physician arrived within two hours—a speed that usually signals clinical concern. While that initial scare resulted only in a lumpectomy and a benign finding, it initiated what Ashman describes as a "terrible subscription box" she could not cancel. For several years, she underwent a repetitive cycle of mammograms, ultrasounds, and biopsies.
In February 2023, the cycle reached a definitive and life-altering conclusion: a diagnosis of Stage 1B invasive ductal carcinoma. This specific diagnosis indicates that the cancer is invasive—meaning it has begun to spread into the surrounding breast tissue—but is still in the early stages, typically characterized by a small tumor and limited, if any, lymph node involvement.
Faced with this reality, Ashman did not retreat. She activated her network. Her first call was to Sharsheret, an organization she had already identified as a potential lifeline during her years of "watchful waiting."
The Role of Sharsheret: Specialized Care for a Diverse Community
Sharsheret (Hebrew for "chain") was founded to address the unique needs of Jewish women, who face a higher hereditary risk for certain cancers. For example, individuals of Ashkenazi Jewish descent have a 1 in 40 chance of carrying a BRCA gene mutation—ten times higher than the general population. However, the organization has expanded its reach to serve more than 275,000 women and families of all backgrounds across the United States.
For Ashman, Sharsheret’s support was multifaceted:
- Peer Support: The organization matched Ashman with "Link to Life" mentors—women of similar age and diagnosis who could offer firsthand insights into the treatment process.
- Clinical Guidance: Sharsheret’s staff of genetic counselors and social workers provided a bridge between the clinical data provided by doctors and the emotional reality of the patient.
- Family Resources: Recognizing that a diagnosis affects the entire household, Sharsheret provided "Busy Boxes" for Ashman’s daughter. These kits are designed to engage children and provide them with a sense of security and distraction while their parents undergo treatment.
"They don’t just answer your questions," Ashman noted. "They hold your hand through every scan, every test, every sleepless night."
The Power of the Team: Mamanet and the "Community in Motion"
While Sharsheret provided the professional safety net, Mamanet provided the social and physical engine for Ashman’s recovery. Mamanet is more than a sports league; it is a cultural phenomenon among mothers, blending the rules of volleyball and catchball with a fierce emphasis on female empowerment.
When Ashman was sidelined by her diagnosis and subsequent treatments, her Mamanet team transitioned from teammates to a mobilized support unit. The team dedicated a full night of play to her recovery, utilizing the league’s platform to raise funds and awareness.
"These women didn’t just cheer from the sidelines—they showed up," Ashman said. "They reminded me that the same women who dive across the court to save a ball would also dive into my life to lift me up." This "community in motion" provided a critical psychological benefit: normalcy. By maintaining her connection to the team, Ashman was able to view herself as an athlete in recovery rather than just a patient in treatment.
Supporting Data: Why Early Detection is the Ultimate Defense
The core of Ashman’s advocacy lies in the empirical data surrounding early detection. According to the American Cancer Society and the National Cancer Institute (NCI), the stage at which breast cancer is diagnosed significantly impacts the prognosis.
- Survival Rates: The five-year survival rate for localized breast cancer (Stage 0 or Stage 1) is 99%. For regional cancer (Stage 2 or 3), the rate is approximately 86%. If the cancer reaches the distant stage (Stage 4), the rate drops to 30%.
- Screening Efficacy: Regular mammograms can detect tumors up to two years before they can be felt by a patient or a physician.
- The "Normalcy" Factor: Beyond survival, early detection often allows for less aggressive treatment options. Patients diagnosed early may avoid the most debilitating forms of chemotherapy or radical surgeries, allowing them to maintain their professional and family lives—what Ashman calls "saving normalcy."
Official Responses and Expert Context
Health experts and advocates emphasize that the "Ashman Model"—combining clinical vigilance with robust social support—is the gold standard for modern cancer care.
In a statement regarding the importance of organizations like Sharsheret, healthcare advocates point out that clinical outcomes are often tied to a patient’s mental health and support system. "A diagnosis of invasive ductal carcinoma is a significant psychological trauma," says one oncology social worker. "When a patient has access to peer support and family-centric resources, their adherence to treatment protocols and their overall quality of life improve significantly."
Furthermore, Sharsheret’s leadership emphasizes that their mission is to ensure no woman faces the disease in isolation. By providing culturally competent care and addressing the specific genetic risks of the Jewish community, they fill a gap that general hospital systems often overlook.
Implications: A Call to Action for Women’s Health
Tori Ashman’s journey from the Mamanet court to the oncology clinic serves as a powerful reminder of the resilience of the human spirit when backed by a dedicated community. Her story carries three primary implications for women’s health advocacy:
1. The De-stigmatization of the "Wait": Ashman’s experience with years of biopsies and scans before a final diagnosis highlights the "limbo" many women experience. Her story encourages women to build their support networks before a crisis hits.
2. The Integration of Sport and Healing: The Mamanet model suggests that physical activity and team-based social structures can be vital components of a holistic recovery plan, providing a sense of agency and physical strength.
3. The Urgency of Screening: Ashman’s final plea is a pragmatic one. "Early detection doesn’t just save lives; it saves normalcy. It means you still get to make dinner, go to work, and show up to Mamanet practice."
Today, Tori Ashman remains a vibrant member of both her family and her team. Her battle with Stage 1B cancer was won not just through medical intervention, but through the collective strength of a sisterhood that refused to let her play the game alone. As she continues to advocate for Sharsheret and early screening, her message remains clear: the "safety net" of community is as essential as the "safety net" of medicine.
If you or someone you love has been impacted by breast or ovarian cancer, or if you want to learn more about your risk and support options, contact Sharsheret at [email protected].
About the Author
